Countries India
The $100 Billion Question: Can India Lead the Global Diabetes Economy?
India’s Diabetes Burden and Global Stakes: India is often called the “diabetes capital of the world,” and not without reason. Recent esti...
September 24, 2025 | Analysis | By editor@biopharmaapac.com
The State of Biotech and Life Science Jobs in Asia Pacific – 2025
In 2025, Asia-Pacific has emerged as the fastest-growing hub for biotech and life sciences employment, fuelled by a powerful combination of government supp...
September 09, 2025 | Report
Top 25 Biotech & Biopharma Leaders in Sustainable Innovation, 2025
In 2025, sustainable innovation has become a core focus in biotechnology and biopharmaceutical industries worldwide. Private companies are at the forefront...
September 08, 2025 | Analysis
Cold Chain Technologies accelerates APAC expansion with new hubs, distributors, and manufacturing site
Cold Chain Technologies (CCT), has reinforced its commitment to expanding its Asia Pacific (APAC) presence with a series of investments and partnerships. ...
August 28, 2025 | News
Piramal Pharma Solutions and NewAmsterdam Pharma Expand Global OSD Manufacturing with Facilities in USA and India
Piramal Pharma Solutions, a global leader in contract development and manufacturing (CDMO) and part of Piramal Pharma Ltd. (NSE: PPLPHARMA) (BSE: 543635), ...
August 25, 2025 | News
Asia-Pacific Leads the Charge: Latest Global BioSupplier Technologies of 2025
The first eight months of 2025 have been transformative for biosupplier technologies worldwide. From innovative lab reagents and biomaterials to ad...
August 22, 2025 | Analysis
Spring Bio Solution to Launch LSPedia’s OneScan in India, Europe, and Singapore for Next-Generation Pharma Compliance
LSPedia, a leading provider of pharmaceutical compliance, serialization, and supply chain software solutions, today announced a strategic partnership with ...
August 21, 2025 | News
Shilpa Medicare Becomes World’s First to Gain Approval for NorUDCA, Pioneering Treatment for Over a Billion NAFLD Patients
NAFLD affects 1 in 4 people globally (1.2 billion), with 188 million patients in India—most undiagnosed until irreversible damage...
August 14, 2025 | News
Axplora Invests €6.5 Million to Expand Vizag Facility as USFDA-Cleared Indian Sites Strengthen Global Strategy
Axplora, a global leader in API small molecule manufacturing, today announced a significant investment at its Vizag site in India to expand production ca...
August 06, 2025 | News
Alveolus Bio Secures Strategic Investment from Shilpa Medicare to Advance Inhaled Microbiome Therapeutics
Alveolus Bio, a pioneering respiratory drug development biotech company founded by Dr. Vivek Lal from University of Alabama at Birmingh...
August 04, 2025 | News
Agilent Technologies Unveils Biopharma Experience Centre in Hyderabad to Accelerate India’s Life Sciences Innovation
Agilent Technologies, a global leader in life sciences, diagnostics, and applied chemical markets, announced the inauguration of its state-of-the-art...
August 01, 2025 | News
3 Trillion-Dollar Sectors, 2 Nations, 1 Game-Changing Deal: UK-India FTA and the Future of Life Sciences
UK-India FTA and Life Sciences: A Strategic Partnership for Growth The UK-India trade relationship has been evolving rapidly, culminating in a landmark Fr...
July 28, 2025 | Analysis
India’s Life Sciences Industry Faces a Defining Moment Amid Shifting U.S. Drug Policies and Regulatory Scrutiny
India’s life sciences industry has grown at a remarkable pace over the past two decades, transforming into a global manufacturing powerhouse. Indian ...
June 25, 2025 | Opinion | By Sidley Austin partners Arif S. Noorani and Ryan Tan
Novo Nordisk Launches Anti-Obesity Drug Wegovy in India for Chronic Weight Management and Cardiovascular Risk Reduction
Danish pharmaceutical major Novo Nordisk has officially launched its anti-obesity therapy Wegovy in India. The once-weekly injectable treatment is approved...
June 24, 2025 | News
Most Read
- Innovations In Magnetic Resonance Imaging Introduced By United Imaging
- Management of Relapsed/Refractory Multiple Myeloma
- 2025 Drug Approvals, Decoded: What Every Biopharma Leader Needs to Know
- BioPharma Manufacturing Resilience: Lessons From Capacity Expansion and Supply Chain Resets from 2025
- APAC Biopharma Review 2025: Innovation, Investment, and Influence on the Global Stage
- Top 25 Biotech Innovations Redefining Health And Planet In 2025
- How Health Systems Are Reshaping Drug Adoption, Partner Models, and Market Access in 2026
- The New AI Gold Rush: Western Pharma’s Billion-Dollar Bet on Chinese Biotech
- Single-Use Systems Are Rewiring Biopharma Manufacturing
- The State of Biotech and Life Science Jobs in Asia Pacific – 2025
- Asia-Pacific Leads the Charge: Latest Global BioSupplier Technologies of 2025
- Invisible Threats, Visible Risks: How the Nitrosamine Crisis Reshaped Asia’s Pharmaceutical Quality Landscape
Bio Jobs
- The State of Biotech and Life Science Jobs in Asia Pacific – 2025
- Avantor’s New CEO Ligner Aims to Unlock Global Potential and Deliver Shareholder Value
- AstraZeneca Commits $50 Billion to U.S. Expansion by 2030 in Biggest-Ever Global Investment
- Thermo Fisher, SAMRC, and South Africa’s Department of Science and Innovation Launch CATIR to Nurture Next-Gen Scientists
- Cube Biotech Appoints Former Sartorius CEO Dr. Joachim Kreuzburg to Board of Directors
- FDA’s AI Transition Marks a Turning Point in Drug Review: Industry Faces Pressure to Adapt Amid 20% Workforce Cut
- WuXi XDC Completes Mechanical Build of Singapore Bioconjugate Manufacturing Hub
News
Editor Picks
